Metastatic liver tumors (Q34110982)

31 July 2017

1 reference

title

Metastatic liver tumors (English)

1 reference

31 July 2017

McCarter MD

1

1 reference

31 July 2017

Fong Y

series ordinal

2

1 reference

31 July 2017

publication date

1 September 2000

1 reference

Journal of Surgical Oncology

31 July 2017

published in

1 reference

31 July 2017

volume

19

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

177-188

1 reference

31 July 2017

cites work

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

21 January 2018

Cancer statistics, 1995.

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Prognosis of carcinoma of the large bowel in the presence of liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Surgical Treatment of Hepatic Metastases From Colorectal Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

5FU infusion with mitomycin-C versus 5FU infusion with methyl-CCNU in the treatment of advanced colon cancer.A southwest oncology group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma. Assessment of activity and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Superiority of sequential methotrexate, fluorouracil, and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Factors affecting survival in patients presenting with synchronous hepatic metastases from colorectal cancer: a clinical and computer analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

A randomized study of two different schedules of methyl CCNU, 5-FU and vincristine for metastatic colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Hepatic resection for metastases from colorectal carcinoma is of dubious value

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Resection of hepatic metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Hepatic resection for metastatic colorectal cancer results in cure for some patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

A new technique for hepatic infusional chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Morbidity and mortality after hepatic resection of metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Resection of hepatic and pulmonary metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Hepatic resection in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Repeated hepatic resection for recurrent metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Recurrence of colorectal cancer after hepatic resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Repeat hepatectomy for colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Repeat hepatectomy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Resection of 'recurrent' colorectal metastases to the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Surgical therapy for recurrent liver metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Repeat hepatic resection as effective treatment of recurrent colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Repeat liver resection for recurrent colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Neuroendocrine metastases of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Survival after liver resection for secondary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Hepatic metastases from soft-tissue sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Cryosurgery of liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Treatment of hepatic metastases by cryotherapy and regional cytotoxic perfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Hand-assisted laparoscopic liver resection: lessons from an initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Neoplastic pancreaticobiliary duct obstruction: evaluation with breath-hold MR cholangiopancreatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

Survival of patients at pennsylvania hospital with hepatic metastases from carcinoma of the colon and rectum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

10.1002/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference